Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients

[1]  R. Bouchentouf.  Thoracic manifestations of sickle cell disease , 2015 .

[2]  D. Neuberg,et al.  Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. , 2013, Blood.

[3]  Stanislav S Zakharenko,et al.  Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin. , 2012, Blood.

[4]  Peter Carmeliet,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[5]  T. Whiteside,et al.  Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells* , 2009, The Journal of Biological Chemistry.

[6]  A. Usheva,et al.  Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice , 2009, Purinergic Signalling.

[7]  Jason B. Caboot,et al.  Pulmonary complications of sickle cell disease in children , 2008, Current opinion in pediatrics.

[8]  D. Yellon,et al.  Human in vivo research on the vascular effects of adenosine. , 2008, European journal of pharmacology.

[9]  Tiejuan Mi,et al.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. , 2008, The Journal of clinical investigation.

[10]  S. Heck,et al.  Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models , 2007, American journal of hematology.

[11]  D. Friedman,et al.  CD39 and control of cellular immune responses , 2007, Purinergic Signalling.

[12]  K. Varani,et al.  Adenosine and lymphocyte regulation , 2007, Purinergic Signalling.

[13]  A. Kutlar.  Sickle Cell Disease: A Multigenic Perspective of a Single Gene Disorder , 2007, Medical principles and practice : international journal of the Kuwait University, Health Science Centre.

[14]  S. Colgan,et al.  The FASEB Journal • Research Communication HIF-dependent induction of adenosine A2B receptor in hypoxia , 2022 .

[15]  P. Correia‐de‐Sá,et al.  Corpus Cavernosum from Men with Vasculogenic Impotence Is Partially Resistant to Adenosine Relaxation due to Endothelial A2B Receptor Dysfunction , 2006, Journal of Pharmacology and Experimental Therapeutics.

[16]  Ärztlicher Direktor,et al.  Endothelial Catabolism of Extracellular Adenosine during Hypoxia : Role of Surface Adenosine Deaminase and CD 26 , 2008 .

[17]  J. B. Martínez,et al.  Lung Function and Airway Hyperresponsiveness in Adult Patients with Sickle Cell Disease , 2006, The American journal of the medical sciences.

[18]  E. Shevach,et al.  The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells , 2006, Immunological reviews.

[19]  Pál Pacher,et al.  Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.

[20]  Tiejuan Mi,et al.  Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase-Deficient Mice1 , 2005, The Journal of Immunology.

[21]  A. Ohta,et al.  The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? , 2005, Trends in immunology.

[22]  S. Colgan,et al.  Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. , 2004, Blood.

[23]  L. Turka,et al.  Tregs and transplantation tolerance. , 2004, The Journal of clinical investigation.

[24]  M. Claesson,et al.  CD4+CD25+ regulatory T cells: I. Phenotype and physiology , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[25]  Manfred Thiel,et al.  Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. , 2004, Annual review of immunology.

[26]  K. Jacobson,et al.  Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium , 2003, The Journal of experimental medicine.

[27]  M. Sitkovsky,et al.  The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. , 2003, Microbes and infection.

[28]  P. Svenningsson,et al.  Pharmacology of adenosine A2A receptors and therapeutic applications. , 2003, Current topics in medicinal chemistry.

[29]  M. Gladwin,et al.  Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. , 2003, The Journal of clinical investigation.

[30]  A. Gerbes,et al.  [Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage]. , 2002, Zeitschrift fur Gastroenterologie.

[31]  T. Wun,et al.  Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. , 2002, Clinical and laboratory haematology.

[32]  P. Frenette.  Sickle cell vaso-occlusion: multistep and multicellular paradigm , 2002, Current opinion in hematology.

[33]  M. Blackburn,et al.  Adenosine-Dependent Airway Inflammation and Hyperresponsiveness in Partially Adenosine Deaminase-Deficient Mice1 , 2001, The Journal of Immunology.

[34]  G. McCaughan,et al.  CD26: A Multifunctional Integral Membrane and Secreted Protein of Activated Lymphocytes , 2001, Scandinavian journal of immunology.

[35]  M. Cappellini,et al.  Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Vercellotti,et al.  Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. , 2000, Blood.

[37]  J Horan,et al.  Prediction of adverse outcomes in children with sickle cell disease. , 2000, The New England journal of medicine.

[38]  L. Thompson,et al.  Ecto‐enzyme and signaling functions of lymphocyte CD 7 3 , 1998, Immunological reviews.

[39]  C. Lluis,et al.  Enzymatic and extraenzymatic role of ecto‐adenosine deaminase in lymphocytes , 1998, Immunological reviews.

[40]  Steve Huang,et al.  Memory of Extracellular Adenosine A2A Purinergic Receptor-mediated Signaling in Murine T Cells* , 1997, The Journal of Biological Chemistry.

[41]  H. Bunn.  Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.

[42]  A. Kosar,et al.  Adenosine: a new agent in the diagnosis of impotence. , 1994, International journal of impotence research.

[43]  R. Katholi,et al.  Control of Artifacts in Plasma Adenosine Determinations , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[44]  M. Weyden,et al.  Adenosine deaminase deficiency and severe combined immunodeficiency disease. , 1977, Life sciences.

[45]  S. Chen,et al.  Detection of the carrier state in combined immunodeficiency disease associated with adenosine deaminase deficiency. , 1974, The Journal of clinical investigation.

[46]  Yang Xia,et al.  Detrimental effects of adenosine signaling in sickle cell disease , 2011, Nature Medicine.

[47]  M. J. Broekman,et al.  CD39/NTPDase-1 activity and expression in normal leukocytes. , 2007, Thrombosis research.

[48]  Courtney M. Lappas,et al.  A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. , 2005, Journal of immunology.

[49]  M. Sitkovsky,et al.  Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. , 2005, Nature reviews. Immunology.

[50]  M. Zago,et al.  Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia. , 2004, Haematologica.